Eye drop nanoparticles that shrink over time overcome the eye's natural defenses, delivering protein drugs to the retina and ...

The company applies AI to optimize molecules across discovery and production with aims to contribute to the rebuilding of U.S.-based drug innovation and manufacturing.

New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and ...

UAE-based CE‑Ventures, the VC arm of Crescent Enterprises, has participated in a $55 million Series A funding round for ...

Welcome, everyone, to the JPMorgan Healthcare Conference. We are pleased to have with us the Almirall management team here with us today, Carlos Gallardo, Chairman and CEO; Karl Ziegelbauer, CFO; Jon ...

Many people are familiar with histamine, a biological molecule, that serves as a key driver of allergic reactions and other ...

Insilico will lead the IND submission and Phase 1 clinical trial of ISM8969, after which Hygtia Therapeutics will take responsibility for further clinical development, regulatory filings, and ...

Henry Gosebruch, who has $3.5 billion in capital to deploy, is thinking broad as he steers the decades-old biotech out of ...

After J.P. Morgan, biotech’s bold promises meet real-world challenges. In 2026, success starts with a CDMO partner who ...

Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for ...

As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma, biotech, and industrial biology. Ainnocence is expanding partnerships, ...

New data marks a major milestone in the nation’s fight against cancer: the five‑year relative survival rate for all cancers ...